Literature DB >> 25500867

A structural perspective on nuclear receptors as targets of environmental compounds.

Vanessa Delfosse1, Albane le Maire1, Patrick Balaguer2, William Bourguet1.   

Abstract

Nuclear receptors (NRs) are members of a large superfamily of evolutionarily related transcription factors that control a plethora of biological processes. NRs orchestrate complex events such as development, organ homeostasis, metabolism, immune function, and reproduction. Approximately one-half of the 48 human NRs have been shown to act as ligand-regulated transcription factors and respond directly to a large variety of endogenous hormones and metabolites that are generally hydrophobic and small in size (eg, retinoic acid or estradiol). The second half of the NR family comprises the so-called orphan receptors, for which regulatory ligands are still unknown or may not exist despite the presence of a C-terminal ligand-binding domain, which is the hallmark of all NRs. Several chemicals released into the environment (eg, bisphenols, phthalates, parabens, etc) share some physicochemical properties with natural ligands, allowing them to bind to NRs and activate or inhibit their action. Collectively referred to as endocrine disruptors or endocrine-disrupting chemicals (EDCs), these environmental pollutants are highly suspected to cause a wide range of developmental, reproductive, neurological, or metabolic defects in humans and wildlife. Crystallographic studies are revealing unanticipated mechanisms by which chemically diverse EDCs interact with the ligand-binding domain of NRs. These studies thereby provide a rational basis for designing novel chemicals with lower impacts on human and animal health. In this review, we provide a structural and mechanistic view of endocrine disrupting action using estrogen receptors α and β, (ERα/β), peroxisome proliferator activated receptor γ (PPARγ), and their respective environmental ligands as representative examples.

Entities:  

Year:  2014        PMID: 25500867      PMCID: PMC4571321          DOI: 10.1038/aps.2014.133

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  90 in total

Review 1.  Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Authors:  B Desvergne; W Wahli
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

Review 2.  Principles for modulation of the nuclear receptor superfamily.

Authors:  Hinrich Gronemeyer; Jan-Ake Gustafsson; Vincent Laudet
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

Review 3.  A structural view of nuclear hormone receptor: endocrine disruptor interactions.

Authors:  Albane le Maire; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2010-01-09       Impact factor: 9.261

Review 4.  Endocrine-disrupting chemicals: associated disorders and mechanisms of action.

Authors:  Sam De Coster; Nicolas van Larebeke
Journal:  J Environ Public Health       Date:  2012-09-06

Review 5.  International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.

Authors:  Liliane Michalik; Johan Auwerx; Joel P Berger; V Krishna Chatterjee; Christopher K Glass; Frank J Gonzalez; Paul A Grimaldi; Takashi Kadowaki; Mitchell A Lazar; Stephen O'Rahilly; Colin N A Palmer; Jorge Plutzky; Janardan K Reddy; Bruce M Spiegelman; Bart Staels; Walter Wahli
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

Review 6.  Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present).

Authors:  Christina Lamers; Manfred Schubert-Zsilavecz; Daniel Merk
Journal:  Expert Opin Ther Pat       Date:  2012-06-15       Impact factor: 6.674

7.  Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice.

Authors:  Marie K Lindberg; Sofia Movérare; Stanko Skrtic; Hui Gao; Karin Dahlman-Wright; Jan-Ake Gustafsson; Claes Ohlsson
Journal:  Mol Endocrinol       Date:  2003-02

8.  Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.

Authors:  Sun-Sil Choi; Byung-Yoon Cha; Young-Sil Lee; Takayuki Yonezawa; Toshiaki Teruya; Kazuo Nagai; Je-Tae Woo
Journal:  Life Sci       Date:  2009-04-17       Impact factor: 5.037

9.  Molecular recognition of nitrated fatty acids by PPAR gamma.

Authors:  Yong Li; Jifeng Zhang; Francisco J Schopfer; Dariusz Martynowski; Minerva T Garcia-Barrio; Amanda Kovach; Kelly Suino-Powell; Paul R S Baker; Bruce A Freeman; Y Eugene Chen; H Eric Xu
Journal:  Nat Struct Mol Biol       Date:  2008-07-06       Impact factor: 15.369

Review 10.  Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review.

Authors:  Bogna Grygiel-Górniak
Journal:  Nutr J       Date:  2014-02-14       Impact factor: 3.271

View more
  33 in total

Review 1.  Cosmetics as endocrine disruptors: are they a health risk?

Authors:  Polyxeni Nicolopoulou-Stamati; Luc Hens; Annie J Sasco
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

2.  Homology models of mouse and rat estrogen receptor-α ligand-binding domain created by in silico mutagenesis of a human template: molecular docking with 17ß-estradiol, diethylstilbestrol, and paraben analogs.

Authors:  Thomas L Gonzalez; James M Rae; Justin A Colacino; Rudy J Richardson
Journal:  Comput Toxicol       Date:  2018-11-28

3.  Family reunion of nuclear hormone receptors: structures, diseases, and drug discovery.

Authors:  H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2015-01       Impact factor: 6.150

Review 4.  Implication of environmental estrogens on breast cancer treatment and progression.

Authors:  Thomas L Gonzalez; James M Rae; Justin A Colacino
Journal:  Toxicology       Date:  2019-03-30       Impact factor: 4.221

5.  Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines.

Authors:  Thomas L Gonzalez; Rebecca K Moos; Christina L Gersch; Michael D Johnson; Rudy J Richardson; Holger M Koch; James M Rae
Journal:  Toxicol Sci       Date:  2018-07-01       Impact factor: 4.849

6.  Insights into the activation mechanism of human estrogen-related receptor γ by environmental endocrine disruptors.

Authors:  Erwan Thouennon; Vanessa Delfosse; Rémy Bailly; Pauline Blanc; Abdelhay Boulahtouf; Marina Grimaldi; Alessandro Barducci; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2019-05-24       Impact factor: 9.261

7.  Towards intercrop ideotypes: non-random trait assembly can promote overyielding and stability of species proportion in simulated legume-based mixtures.

Authors:  Gaëtan Louarn; Romain Barillot; Didier Combes; Abraham Escobar-Gutiérrez
Journal:  Ann Bot       Date:  2020-09-14       Impact factor: 4.357

8.  Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ.

Authors:  Chyuan-Chuan Wu; Thomas J Baiga; Michael Downes; James J La Clair; Annette R Atkins; Stephane B Richard; Weiwei Fan; Theresa A Stockley-Noel; Marianne E Bowman; Joseph P Noel; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

Review 9.  Risks and benefits related to alimentary exposure to xenoestrogens.

Authors:  Ilaria Paterni; Carlotta Granchi; Filippo Minutolo
Journal:  Crit Rev Food Sci Nutr       Date:  2017-11-02       Impact factor: 11.176

Review 10.  Mechanisms of action of agrochemicals acting as endocrine disrupting chemicals.

Authors:  Genoa R Warner; Vasiliki E Mourikes; Alison M Neff; Emily Brehm; Jodi A Flaws
Journal:  Mol Cell Endocrinol       Date:  2019-12-12       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.